Health
Rare ‘No-Burp Syndrome’ Gains Attention, But Treatment Remains Costly
A rare condition known as retrograde cricopharyngeal dysfunction (R-CPD), or “no-burp syndrome,” is gaining attention on social media, with medical specialists and affected individuals raising awareness about its impact. Despite growing recognition, treatment options remain expensive and largely inaccessible.
For many individuals, burping is a routine bodily function, but for those with R-CPD, it is impossible. The condition, formally identified in 2019 by Dr. Robert Bastian of the Bastian Voice Institute, prevents the cricopharyngeus muscle in the upper esophagus from relaxing, trapping air in the digestive system. This results in painful bloating, gurgling sounds in the throat, and severe discomfort.
Dulcie, a 23-year-old research student from the UK, experienced these symptoms for years without understanding the cause. “Now I know what R-CPD is, I blame it for many of the barriers to generally good physical and mental health that I face,” she told Euronews Health. She also links her severe phobia of vomiting to the condition, as the pressure buildup in her chest sometimes induces nausea.
Despite increasing awareness, R-CPD remains largely unrecognized by healthcare professionals. “There is a treatment for the condition, but it is not NHS-approved yet because many doctors are unaware of it or don’t consider it a health issue,” said Mr. Yakubu Karagama, a laryngologist at Guy’s and St Thomas’ NHS Foundation Trust. He argues that the condition is often dismissed as a social issue rather than a legitimate medical concern.
The Challenges of Diagnosis and Treatment
Diagnosing R-CPD typically requires an endoscopy, but few doctors specialize in the condition. The most effective treatment currently available is botulinum toxin (Botox) injections into the cricopharyngeus muscle, which helps relax the muscle and allow burping. However, the treatment is costly—upwards of £3,000 (€3,621) through private healthcare in the UK—and is not widely covered by insurance due to the condition’s relatively recent recognition.
A recent study by Texas-based researchers found that individuals with R-CPD were more likely to struggle with anxiety, depression, and social embarrassment, impacting their professional and personal lives. “Sitting up at my desk for full days is actively painful,” Dulcie said. “I can’t do anything in the evenings because I have to lie down for the gurgles and pain to subside.”
For Amelia, a 41-year-old who was formally diagnosed with R-CPD, the condition severely impacted her social life. “I couldn’t drink with my food, couldn’t enjoy nights out or meals out. It was embarrassing, painful, and socially debilitating,” she said. After receiving Botox treatment six years ago at a cost of £5,000 (€6,038), she described it as “the best money I’ve ever spent.”
Alternative Approaches and Hope for the Future
While Botox treatment is effective in about 90% of cases, the procedure carries risks, including temporary acid reflux and swallowing difficulties. Some patients have reported success with alternative methods, such as physical exercises targeting the neck and throat muscles.
Dr. Lee Akst, a laryngologist at Johns Hopkins Medicine, suggests head posture exercises may encourage burping. However, he acknowledges that success rates are anecdotal, with no standardized regimen available.
For now, many individuals suffering from R-CPD continue to push for greater medical recognition and accessibility to treatment. “If this works, it will change my life,” said Dulcie, who is scheduled for treatment soon. “I’ll be able to eat a full meal out with friends without retreating home in discomfort.”
As awareness grows, there is hope that increased research and recognition will lead to broader medical acknowledgment and more affordable treatment options for those living with no-burp syndrome.
Health
Romania Faces Surging Measles Outbreak Amid Vaccine Hesitancy and Healthcare Challenges
Romania is grappling with a severe measles outbreak, fueled by low vaccination rates, a struggling medical system, and widespread misinformation. While the country faces the largest measles crisis in Europe, experts warn that other nations may soon follow.
The outbreak, which has persisted for nearly three years, has intensified, with over 31,000 reported cases and 22 deaths in 2023 alone. Nearly half of the infections occurred in unvaccinated children under the age of five, highlighting the impact of Romania’s declining immunization rates. As of 2023, only 62% of the population was fully vaccinated against measles—well below the 95% threshold needed for herd immunity.
A Widening European Concern
While Romania remains the epicenter, measles is resurging across Europe. Countries such as Italy, Germany, Belgium, Austria, and France have each reported hundreds of cases in the past year, with numbers expected to rise.
“The challenge is all over the region,” said Dr. Dragan Jankovic, who oversees measles elimination at the World Health Organization (WHO) Europe office. “2024 was the worst possible year for measles in Europe since the 1990s. That’s why countries need to act now and start immunizing those who are unprotected.”
According to WHO data, only four EU countries—Hungary, Malta, Portugal, and Slovakia—currently meet the 95% vaccination target. The ongoing decline in routine childhood immunization since the COVID-19 pandemic has raised concerns that measles could become endemic in parts of Europe.
Why Vaccination Rates Are Declining
Romania’s vaccination rate was once on par with other EU countries, but the past decade has seen a sharp decline. A combination of factors—including vaccine hesitancy, supply shortages, healthcare system inefficiencies, and a mass exodus of medical professionals—has contributed to the crisis.
“It’s like the perfect storm ahead of an epidemic,” said Dr. Stefan Dascalu, an immunologist at Oxford University. “If you leave one of these problems untreated, it metastasizes.”
Public mistrust in vaccines deepened during the COVID-19 pandemic, when misinformation and conspiracy theories flourished. Anti-science rhetoric has also gained traction in Romania’s political landscape, with far-right parties leveraging vaccine skepticism to gain influence in parliament.
Romania’s healthcare system remains underfunded, with spending at just 5.8% of GDP—half the EU average. Many Romanians still perceive doctors as corrupt, making them more susceptible to vaccine misinformation. Additionally, while measles vaccines are free and recommended for children, they are not mandatory, and medical professionals are not always adequately trained to administer them or provide clear guidance.
Fighting Misinformation and Encouraging Immunization
Dr. Claudia Cojocaru, a neonatologist in Romania, has become an outspoken advocate for vaccinations after personally battling measles in 2019. She now works to counter vaccine misinformation among skeptical parents.
“I try not to push or mock them,” Cojocaru explained. “I tell them my messenger is always open. If they have concerns, they can ask me.”
Public health experts stress that reversing vaccine hesitancy and rebuilding trust in immunization programs will require long-term efforts, including stronger public health messaging, more investment in healthcare, and improved coordination across European nations.
“No single country is safe from the importation of the virus,” Jankovic warned. “If measles reaches unvaccinated populations, we will see more cases—and unfortunately, more outbreaks.”
Health
Study Links Plant-Based Diet to Healthier Ageing
A new large-scale study has found that following a predominantly plant-based diet while avoiding red meat and ultra-processed foods is associated with better physical and mental health in later life.
The study, published in Nature Medicine, tracked around 105,000 individuals in the United States over a span of 30 years. Researchers analyzed the impact of various dietary patterns, including the Mediterranean diet and the Dietary Approaches to Stop Hypertension (DASH) plan, on long-term health outcomes.
Findings indicated that those who aged healthily—reaching 70 without major chronic illnesses and maintaining good cognitive and physical function—followed diets rich in fruits, vegetables, whole grains, unsaturated fats, nuts, beans, and other legumes. They consumed moderate amounts of animal-based foods, such as low-fat dairy, while avoiding excessive sodium, sugary drinks, red and processed meats, and trans fats commonly found in fried foods.
According to Marta Guasch-Ferré, the study’s senior author and an associate professor at the University of Copenhagen, the research does not pinpoint a single optimal diet but rather emphasizes the benefits of multiple dietary approaches that support overall health. “Maybe there’s not a superfood or a diet that saves us all, but there are different diets that could improve our health,” she told Euronews Health.
Few Achieve Healthy Ageing
Despite the clear benefits of a nutritious diet, the study revealed that fewer than 10% of participants met the criteria for healthy ageing. Unlike previous research that focused mainly on lifespan, this analysis considered overall well-being, including mental health and physical independence.
“Do we really want to live longer, or do we want to live better?” Guasch-Ferré posed, highlighting the study’s emphasis on quality of life rather than longevity alone.
Though conducted in the U.S., researchers believe the findings are relevant to other regions, including Europe. However, they acknowledge certain limitations, such as potential influences from genetics, environment, and healthcare accessibility, despite efforts to account for socioeconomic factors.
Implications for Dietary Guidelines
The results suggest that dietary guidelines could be adjusted to promote healthier ageing, encouraging individuals to make more informed nutritional choices.
“Of course, healthy ageing is not just about diet,” Guasch-Ferré noted, but she emphasized that “any improvement in diet could help.”
The study adds to the growing body of evidence that lifestyle choices, particularly dietary habits, play a crucial role in maintaining health and well-being well into old age.
Health
Europe Sees Surge in Stimulant Drug Use, Wastewater Analysis Reveals
A comprehensive study of wastewater across Europe has revealed a significant rise in the consumption of stimulant drugs, particularly MDMA, cocaine, and amphetamines, across 128 cities in 26 countries.
The research, conducted by the European Union Drugs Agency (EUDA) and the SCORE group, examined the drug-taking habits of approximately 68.8 million people by analyzing wastewater samples. This method enables scientists to measure drug residues excreted in urine, providing an estimate of consumption levels within a given population.
According to the EU, 87 million adults in Europe have used illicit drugs at least once in their lifetime. While cannabis and cocaine remain the most widely used substances, the study noted an increasing trend in the use of MDMA, heroin, synthetic drugs, and psychedelics. The analysis focused on five key stimulants: amphetamine, cocaine, methamphetamine, MDMA, and ketamine, in addition to cannabis.
Cocaine Use on the Rise
The report highlighted that while cocaine use remained relatively stable between 2011 and 2015, consumption began rising significantly from 2016 onward. Western and southern European cities, particularly in Belgium, the Netherlands, and Spain, reported the highest levels of cocaine residues in wastewater.
The 2024 findings show further increases, with 39 of the 72 cities analyzed reporting higher levels compared to 2023. Belgium, in particular, recorded a sharp increase, with Brussels and Antwerp showing significant spikes in daily cocaine consumption. In Brussels, the daily intake per 1,000 inhabitants reached 1,186.34 milligrams in 2024, nearly double the 2023 figure of 598.22 mg. The study also found that cocaine use peaks on Saturdays, indicating its predominant recreational use.
MDMA and Ecstasy Consumption
Belgium, along with Czechia, the Netherlands, and Portugal, also recorded high levels of MDMA use. While ecstasy consumption has fluctuated since 2016, longer-term trends indicate overall growth. Similar to cocaine, MDMA usage is predominantly linked to recreational settings, with consumption surging over the weekends.
Decline in Cannabis Use
Despite the rise in stimulant drug use, cannabis, which remains the most commonly used illicit drug in Europe with an estimated 22.8 million users, saw a decline in consumption across most cities in 2024 compared to previous years.
Wastewater analysis indicates that cannabis use is more widespread in southern and central European countries, particularly Spain, the Netherlands, and Portugal. While cannabis remains illegal in most European nations, certain exceptions exist. Germany, Luxembourg, and Malta have legalized cannabis under specific conditions, while nine other countries allow limited consumption.
Shifting Drug Policies
The European Drug Agency’s 2024 report highlighted the ongoing debate surrounding cannabis regulation in the region. While discussions on policy changes continue, the agency stated that the future direction of European drug laws remains uncertain.
With stimulant use increasing across major cities and cannabis consumption showing a shift, the findings from this study provide valuable insights into the evolving drug landscape in Europe.
-
Business10 months ago
Saudi Arabia’s Model for Sustainable Aviation Practices
-
Business10 months ago
Recent Developments in Small Business Taxes
-
Politics10 months ago
Who was Ebrahim Raisi and his status in Iranian Politics?
-
Business9 months ago
Carrectly: Revolutionizing Car Care in Chicago
-
Business9 months ago
Saudi Arabia: Foreign Direct Investment Rises by 5.6% in Q1
-
Technology10 months ago
Comparing Apple Vision Pro and Meta Quest 3
-
Politics10 months ago
Indonesia and Malaysia Call for Israel’s Compliance with ICJ Ruling on Gaza Offensive
-
Technology10 months ago
Recent Developments in AI Ethics in America